Division of Plastic Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
Department of Surgery, Southern Illinois University School of Medicine, Institute for Plastic Surgery, Springfield, Illinois.
J Reconstr Microsurg. 2020 Jul;36(6):403-411. doi: 10.1055/s-0040-1702151. Epub 2020 Feb 27.
Anastomotic couplers expedite venous microvascular anastomoses and have been established as an equivalent alternative to hand-sewn anastomoses. However, complications unique to the coupler such as palpability and extrusion can occur. The purpose of this study was to perform a systematic review of the literature to assess complications distinct to the venous anastomotic coupler.
A Medline, PubMed, EBSCO host search of articles involving anastomotic venous couplers was performed. Studies involving arterial anastomotic couplers, end-to-side anastomoses, and reviews were excluded. Data points of interest were flap failure, venous thrombosis, hematoma, partial flap necrosis, infection, coupler extrusion, and coupler palpability.
The search identified 165 articles; 41 of these met inclusion criteria. A total of 8,246 patients underwent 8,955 venous-coupled anastomoses. Combined reoperation rate was 3.3% and all-cause unsalvageable flap failure was 1.0%. Complications requiring reoperation included venous thrombosis (2.0%), hematoma (0.4%), partial flap necrosis (0.4%), and infection (0.3%). Eight patients had palpable couplers and 11 patients had extrusion of couplers (head/neck, hand, and feet) and required operative management.
Venous couplers remain an equivalent alternative to conventional hand-sewn anastomosis. However, venous coupler extrusion and palpability in the late postoperative period is a complication unique to anastomotic couplers, particularly in radiated head and neck, feet and hand free flaps. Removing extruded venous couplers is safe after tissue integration 3 weeks postoperatively. Coupler palpability and extrusion should be integrated into preoperative patient counseling and assessed in follow-up examinations.
吻合器可加快静脉显微吻合速度,已被确立为与手工吻合等效的替代方法。然而,吻合器特有的并发症,如可触及性和脱出,也可能发生。本研究旨在对文献进行系统回顾,评估吻合器静脉吻合特有的并发症。
对涉及吻合器静脉吻合的文章进行了 Medline、PubMed、EBSCO 主机搜索。排除了涉及动脉吻合器、端侧吻合和综述的研究。感兴趣的数据点为皮瓣失败、静脉血栓形成、血肿、部分皮瓣坏死、感染、吻合器脱出和吻合器可触及性。
搜索共确定了 165 篇文章,其中 41 篇符合纳入标准。共有 8246 例患者接受了 8955 例静脉吻合器吻合术。联合再手术率为 3.3%,所有原因不可挽救的皮瓣失败率为 1.0%。需要再次手术的并发症包括静脉血栓形成(2.0%)、血肿(0.4%)、部分皮瓣坏死(0.4%)和感染(0.3%)。8 例患者有可触及的吻合器,11 例患者有吻合器脱出(头/颈、手和脚),需要手术治疗。
静脉吻合器仍然是传统手工吻合的等效替代方法。然而,吻合器静脉吻合在术后晚期的脱出和可触及性是吻合器特有的并发症,特别是在放射性头颈部、足部和手部游离皮瓣中。在术后 3 周组织整合后,取出脱出的静脉吻合器是安全的。吻合器的可触及性和脱出应纳入术前患者咨询,并在随访检查中进行评估。